These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2930690)

  • 21. Lonidamine: efficacy and safety in clinical trials for the treatment of solid tumors.
    Di Cosimo S; Ferretti G; Papaldo P; Carlini P; Fabi A; Cognetti F
    Drugs Today (Barc); 2003 Mar; 39(3):157-74. PubMed ID: 12730701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lonidamine alone and in combination with other chemotherapeutic agents in the treatment of cancer patients.
    Pacilio G; Carteni G; Biglietto M; De Cesare M
    Oncology; 1984; 41 Suppl 1():108-12. PubMed ID: 6326014
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A long-term clinical experience with Lonidamine.
    Battelli T; Manocchi P; Giustini L; Mattioli R; Ginnetti A; De Gregorio M; De Martino C; Silvestrini B
    Oncology; 1984; 41 Suppl 1():39-47. PubMed ID: 6717894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluorouracil, doxorubicin, and cyclophosphamide versus fluorouracil, doxorubicin, and cyclophosphamide plus lonidamine for the treatment of advanced breast cancer: a multicentric randomized clinical study.
    Calabresi F; Di Lauro L; Marolla P; Curcio CG; Paoletti G; Calabró A; Giannarelli D; Ballatore P; Foggi CM; Di Palma M
    Semin Oncol; 1991 Apr; 18(2 Suppl 4):66-72. PubMed ID: 2031201
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lonidamine in primary malignant brain tumors. Preliminary report.
    Carapella CM; Iandolo B; Delle Chiaie S; Riccio A
    Oncology; 1984; 41 Suppl 1():82-5. PubMed ID: 6717901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early observations on the administration of Lonidamine in cancer patients.
    Barduagni A; Barduagni M; Di Lauro L; Nardi M; Gallo Curcio C; Tonachella R; Ciottoli GB; Delle Chiaie S
    Oncology; 1984; 41 Suppl 1():78-81. PubMed ID: 6717900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase III trial with and without lonidamine in non-small cell lung cancer.
    Gatzemeier U; Cavalli F; Häussinger K; Kaukel E; Koschel G; Martinelli G; Neuhauss R; von Pawel J
    Semin Oncol; 1991 Apr; 18(2 Suppl 4):42-8. PubMed ID: 1851577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The potential role of lonidamine (LND) in the treatment of malignant glioma. Phase II study.
    Carapella CM; Paggi MG; Cattani F; Ciottoli GB; Floridi A; Iandolo B; Raus L; Riccio A; Caputo A
    J Neurooncol; 1989 May; 7(1):103-8. PubMed ID: 2666593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase II trial of piroxantrone in metastatic breast cancer. A Southwest Oncology Group study.
    Ravdin PM; Green S; Doroshow JH; Martino S
    Invest New Drugs; 1994; 12(4):333-6. PubMed ID: 7775136
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase II double-blind randomized study of lonidamine and radiotherapy in epidermoid carcinoma of the lung.
    Privitera G; Ciottoli GB; Patanè C; Palmucci T; Tafuri G; Marletta F; De Luca B; Magnani F; De Gregorio M; Greco S
    Radiother Oncol; 1987 Dec; 10(4):285-90. PubMed ID: 3444905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Partial response to lonidamine of advanced bladder carcinoma: a case report.
    Lo Re G; Veronesi A; Tumolo S; Morassut S; Belmonte P; Francini M; Monfardini S
    Tumori; 1990 Jun; 76(3):290-1. PubMed ID: 2368176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toxicity and clinical tolerance of lonidamine.
    Robustelli della Cuna G; Pedrazzoli P
    Semin Oncol; 1991 Apr; 18(2 Suppl 4):18-22. PubMed ID: 2031192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elliptinium acetate in metastatic breast cancer--a phase II study.
    Buzdar AU; Hortobagyi GN; Esparza LT; Holmes FA; Ro JS; Fraschini G; Lichtiger B
    Oncology; 1990; 47(2):101-4. PubMed ID: 2314820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lonidamine and hyperthermia: clinical experience in melanoma. Preliminary results.
    Cavaliere R; Di Filippo F; Varanese A; Carlini S; Calabro A; Aloe L; Piarulli L
    Oncology; 1984; 41 Suppl 1():116-20. PubMed ID: 6717890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Morphological damage induced in vivo by Lonidamine on human metastatic cancer cells.
    De Martino C; Battelli T; Cavaliere R; Gallo Curcio C; Bellocci M; Manocchi D; Giustini L; Mattioli R; Rinaldi M; Di Filippo F
    Oncology; 1984; 41 Suppl 1():94-103. PubMed ID: 6717904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lonidamine in high-risk breast cancer patients.
    Possinger K; Wagner H; Kovacs S; Flath B; Classen S; Wilmanns W
    Semin Oncol; 1991 Apr; 18(2 Suppl 4):58-61. PubMed ID: 2031199
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lonidamine and radiotherapy in head and neck cancers. A pilot study.
    Magno L; Terraneo F; Ciottoli GB
    Oncology; 1984; 41 Suppl 1():113-5. PubMed ID: 6717889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modification of tumor cell sensitivity to antineoplastic agents lonidamine and bouvardin (NSC 259968) at elevated temperatures.
    Adwankar MK; Chitnis MP
    Neoplasma; 1986; 33(2):217-23. PubMed ID: 3713924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lonidamine. Proceedings of the IInd international symposium, Vancouver 1982.
    Oncology; 1984; 41 Suppl 1():1-123. PubMed ID: 6717887
    [No Abstract]   [Full Text] [Related]  

  • 40. Cisplatin, epirubicin, and lonidamine combination regimen as first-line chemotherapy for metastatic breast cancer: a pilot study.
    Dogliotti L; Danese S; Berruti A; Zola P; Buniva T; Bottini A; Richiardi G; Moro G; Farris A; Baù MG; Porcile G
    Cancer Chemother Pharmacol; 1998; 41(4):333-8. PubMed ID: 9488603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.